| JXHL1600050 | 尼达尼布软胶囊 | nintedanib | Soft capsules | Chemical Drugs | Import Drug Application | 2016-05-10 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2018-03-09 | view |
| JXHL1600051 | 尼达尼布软胶囊 | nintedanib | Soft capsules | Chemical Drugs | Import Drug Application | 2016-05-10 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2018-03-26 | view |
| JYHB1401349 | 达比加群酯胶囊 | dabigatran etexilate | Capsule | Chemical Drugs | Supplementary Application | 2014-10-15 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2016-11-15 | view |
| JYHB1401350 | 达比加群酯胶囊 | dabigatran etexilate | Capsule | Chemical Drugs | Supplementary Application | 2014-10-15 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2016-11-15 | view |
| JYHB1401351 | 达比加群酯胶囊 | dabigatran etexilate | Capsule | Chemical Drugs | Supplementary Application | 2014-10-15 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2016-11-15 | view |
| JYHB1401352 | 达比加群酯胶囊 | dabigatran etexilate | Capsule | Chemical Drugs | Supplementary Application | 2014-10-15 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2016-11-15 | view |
| JYHB1401709 | 丁溴东莨菪碱注射液 | scopolamine butylbromide | Injection | Chemical Drugs | Supplementary Application | 2014-12-23 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2016-07-25 | view |
| JYHB1401710 | 丁溴东莨菪碱注射液 | scopolamine butylbromide | Injection | Chemical Drugs | Supplementary Application | 2014-12-23 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2016-07-25 | view |
| JYHB1600546 | 替米沙坦片 | telmisartan | Tablet | Chemical Drugs | Supplementary Application | 2016-05-06 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2017-08-29 | view |
| JYHB1600547 | 替米沙坦片 | telmisartan | Tablet | Chemical Drugs | Supplementary Application | 2016-05-06 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2017-08-29 | view |
| JYHB1600548 | 替米沙坦片 | telmisartan | Tablet | Chemical Drugs | Supplementary Application | 2016-04-21 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2017-08-29 | view |
| JYHB1600549 | 替米沙坦片 | telmisartan | Tablet | Chemical Drugs | Supplementary Application | 2016-04-21 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2017-08-29 | view |
| JYHB2000816 | 美洛昔康注射液 | meloxicam | Injection | Chemical Drugs | Supplementary Application | 2020-06-12 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Filed | 2020-06-19 | view |
| JYHZ1700051 | 替米沙坦氢氯噻嗪片 | hydrochlorothiazide;telmisartan | Tablet | Chemical Drugs | License Renew | 2017-08-24 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2017-10-19 | view |
| JYHZ2000026 | 美洛昔康注射液 | meloxicam | Injection | Chemical Drugs | License Renew | 2020-03-11 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2020-07-31 | view |
| JYHZ2000027 | 美洛昔康注射液 | meloxicam | Injection | Chemical Drugs | License Renew | 2020-02-25 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2020-07-31 | view |
| JYSB1400248 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2014-12-10 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2016-12-08 | view |
| JYSB1400249 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2014-12-10 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2016-12-08 | view |
| JYSB1700050 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2017-05-04 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2017-07-17 | view |
| JYSB1700051 | 注射用阿替普酶 | alteplase | Lyophilized | Biological Products | Supplementary Application | 2017-05-04 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2017-07-17 | view |
